Skip to main content
. 2003 Dec;47(12):3789–3794. doi: 10.1128/AAC.47.12.3789-3794.2003

TABLE 3.

Urinary pH and volume, parent drug concentration in urine and cumualtive excretion in the volunteersa

Drug and collection period (h) Urinary pH Vol (ml) Concn (mg/liter) % Cumulative excretion
Median (range) Mean ± SD
Linezolid
    0-6 5.9c (5.2-6.5) 532 (182-1,135) 192.0c (104-497) 16.9c (10.0-26.6) 17.0 ± 5.0
    6-12 7.7 (6.2-8.7) 947 (515-1,353) 82.0c (66-163) 30.6c (19.5-40.4) 29.7 ± 6.5
    12-24 6.3 (5.5-7.1) 824 (413-954) 61.0c (37-139) 40.4 (26.6-45.6) 37.0 ± 7.1
    24-36 6.7 (5.6-8.0) 1,236 (432-3,160) 7.8c (5.3-51) 43.4 (28.1-46.5) 39.3 ± 7.7
    36-48 6.2c (5.7-6.6) 712 (334-1,630) 3.1c (1.2-9.4) 43.7 (28.2-46.7) 39.7 ± 7.7
    48-72 6.3 (5.6-7.0) 1,432 (784-2,450) 0.6d (0.2-4.3) 43.9 (28.2-47.1) 39.9 ± 7.8
    72-96 6.0 (5.8-6.8) 1,661 (784-3,132) 0.1d (0.1-1.0) 43.9 (28.2-47.2) 39.9 ± 7.8
    96-120 6.1 (5.2-8.5) 1,333 (684-2,241) 0.1d (0.02-0.2) 43.9 (28.2-47.2) 39.9 ± 7.8
Ciprofloxacin
    0-6 6.1c (5.4-6.5) 353 (170-1,628) 407.0c (23-733) 31.5c (7.5-50.2) 30.5 ± 10.3
    6-12 7.2 (6.2-8.9) 643 (376-1,485) 47.0c (19-76) 38.6c (14.9-53.9) 36.5 ± 9.7
    12-24 6.3 (5.9-7.7) 575 (410-1,543) 24.0c (5.8-36) 41.4 (18.9-55.5) 39.0 ± 9.3
    24-36 7.0 (5.6-8.3) 1,096 (566-2,213) 2.0c (0.9-4.9) 42.0 (19.4-56.0) 39.5 ± 9.3
    36-48 6.5c (5.8-8.0) 709 (474-1,163) 1.6c (0.6-3) 42.2 (19.7-56.1) 39.8 ± 9.3
    48-72 6.1 (5.4-7.0) 1,688 (864-2,042) BQLb,d (BQL-1.6) 42.6 (19.7-56.1) 39.9 ± 9.3
    72-96 6.1 (5.5-7.8) 1,448 (570-2,697) BQLd 42.6 (19.7-56.1) 39.9 ± 9.3
    96-120 6.5 (5.7-8.0) 1,299 (544-2,535) BQLd (BQL-0.6) 42.6 (19.7-56.1) 39.9 ± 9.3
a

A total of 12 volunteers were tested. The values are given as medians (ranges) unless indicated otherwise.

b

BQL, below quantification limit (0.0098 mg/liter for linezolid; 0.559 mg/liter for ciprofloxacin).

c

Significantly different (P < 0.05) for linezolid versus ciprofloxacin.

d

Calculation not applicable.